Group items tagged

ACL/PCL repair by Indian surgeons in Nigeria is benefitting lots of Nigerian patients for quality procedures and safety. Consistent success rate and affordable rates for ACL/PCL repair procedures by Experts doctors offering a quality life to men and… Read More »

Dr. Carl Wierks, Holland Bone & Joint Center, treats knee pain in athletes including Anterior Cruciate Ligament (ACL) Reconstruction, lateral meniscus repair and tendon damage. 616.738.4420 or visit http://hollandboneandjoint.com for treatment worth the travel!

Dr. Carl Wierks, Holland Bone & Joint Center, treats knee pain in athletes including Anterior Cruciate Ligament (ACL) Reconstruction, lateral meniscus repair and tendon damage. 616.738.4420 or visit http://hollandboneandjoint.com for treatment worth the travel!

Tynor Functional Knee Support is specially designed to support knees which are injured or not working properly due to old age. It stabilizes knees during rotational and anteroposterior forces and cures the ligamentous knee injuries. It provides support to the knees by wrapping around them and thus facilitates their compression. It provides flexibility and easy movement of the knee. It is made of soft, durable fabric which can be stretched in four ways. It mimics the natural knee joint. It can bear the load and shock exerted on it from the external forces leaving the knee totally free from pressure. It contains no buckling or vaso constriction which might hinder comfort. It ensures the proper circulation of blood. It compresses the patellar region and hold it in right position and thus can be used for patellofemoral diseases. It is easy to maintain. Tynor Functional Knee Support Functional knee Support is an anterior opening device, which offers the advantage of controlled compression around the knee and a rigid lateral support and immobilization. It allows normal flexion and free movement of the knee joint. Anterio Open able Easy application Controlled compression. Perfect lateral splinting. Anatomical design. Tynor Functional Knee Support Features Bi axial heavy duty aluminum hinge Mimics the natural knee joint Ensures full weight bearing. Allows free flexion movement Four way stretchable fabric Controlled and comfortable compression No buckling No vaso constriction Enhanced comfort Open patella design Release patellar pressure Hold the patella in position Can be used for Patellofemoral diseases Wrap design with anterior closing Easy application and removal on swollen or asymmetric knees Easy application and removal for weak or geriatric patients. Allows customized compression Offers flexibility in sizing Ergonomic design Anti tourniquet effect - ensures no constriction to blood flow Better grip of the product to the bo

Vissco Limited Motion Knee Brace Another Vissco product specifically designed to help ease that nasty knee pain. This knee brace helps to achieve a controlled range of motion to facilitate recovery from a muscle pull, strain, ligament tear or knee operation. WHEN TO USE Postoperative rehabliation for knee joint For controlled range of motion of knee Ligament injury - Grade 1 (ACL/PCL/MCL/LCL) Meniscus injuries - Grade 1 Vissco Limited Motion Knee Brace Features Hinged Support Universal Fit Adjustable Support Anti-Fungal Vissco Limited Motion Knee Brace Measurements

Esperion Therapeutics' non-statin therapy "bempedoic acid" has shown modest results in reducing the risk of major cardiovascular events in statin-intolerant patients in the cholesterol lowering via bempedoic acid, an ACL-inhibiting regimen (CLEAR Outcomes) trial, revealed GlobalData, a leading data and analytics company. As a result, there is substantial room for improvement in this space as a potential approval is expected in Australia in near-term based on these results, said GlobalData. According to GlobalData's Pharmaceutical Intelligence Center, the total number of diagnosed prevalent cases of dyslipidemia in Australia is expected to increase at a compound annual growth rate of approximately 1.2% from 5.2 million in 2022 to 5.4 million in 2025. Neha Myneni, Pharma Analyst at GlobalData, comments: "Bempedoic acid joins several statin alternatives that have shown the potential to reduce cardiac illnesses. However, with not much significant improvement in the outcomes, there exists a clear room for improvement for non-statin therapies in this space." Bempedoic acid is the sixth class of cholesterol-lowering drugs (other than cholesteryl-ester transfer protein isoform (CETPi) inhibitors), that has demonstrated the potential to reduce heart attacks and strokes. Other class of therapies with similar potential currently marketed in Australia include statins, bile acid resins, niacin, ezetimibe, and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (alirocumab, evolocumab, and inclisiran).